.png){kind=icon}
.png){kind=icon}
Return
68Ga-FAPI-04 PET/CT: a new horizon for evaluating pulmonary involvement in MDA5+ dermatomyositis
.png){kind=icon}
OA
AI
Y
Y
W
Z
W
Y
Z
H
W
L
L
C
Y
DOI：10.1186/s12931-026-03831-y.png)
.png){kind=icon}
Original request for help.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
MDA5+ dermatomyositis (MDA5+DM) frequently complicates interstitial lung disease (ILD), especially rapidly progressive ILD (RP-ILD), which worsens prognosis. Traditional assessments cannot directly reflect fibroblast activation status, a key driver of pulmonary fibrosis. 68Ga-FAPI-04 PET/CT targets fibroblast activation protein (FAP), but its value in MDA5+DM remains understudied. Fourteen MDA5+DM patients and 5 controls were enrolled. 68Ga-FAPI-04 PET/CT was performed to obtain SUVmax of lungs, muscles, and other organs. Clinical data, pulmonary function tests, and deep learning-quantified HRCT indices were collected. Follow-ups for pulmonary function and HRCT were conducted. Correlations between SUVmax, clinical features, and follow-up outcomes were analyzed. Whole-lung SUVmax was significantly higher in MDA5+DM patients (3.32 vs. 0.67, p < 0.0001), with left lower lobe showing the most prominent difference (p = 0.0003). SUVmax strongly correlated with HRCT inflammation/fibrosis indices (e.g., left lower lobe vs. PII at 3 months: r = 0.9863, p < 0.0001) and small-to-medium airway function (lung vs. MMEF 75/25: r=-0.8168, p = 0.0133). Baseline SUVmax predicted 3–12-month lesion progression and lung function changes, with deceased patients having higher baseline whole-lung SUVmax (p = 0.008). This exploratory study suggests that 68Ga-FAPI-04 PET/CT may reflect fibroblast activation and the active inflammatory-fibrotic process, assesses early pulmonary impairments and monitoring lesion progression in MDA5+DM. It provides a valuable hypothesis-generating tool for clinical evaluation, warranting further validation.
Keywords:
MDA5-positive dermatomyositis
68Ga-FAPI-04 PET/CT
Interstitial lung disease
Fibroblast activation protein
Journal
IF:
5
Papers:
803
Citations:
1.5W
Organization
Cited Papers